- Zacks•3 hours ago
The Zacks Analyst Blog Highlights: IBM, Allergan, Chubb, DISH Network and HP
- PR Newswire•4 hours ago
DUBLIN, Feb. 27, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced that Lisa DeFrancesco, Vice President of Investor Relations, has decided to leave Allergan to pursue other professional opportunities. "After nearly 8 years of leading the Investor Relations function during the transformation of our Company from Watson, a U.S. focused generics company, to Actavis, a leading global generics company to Allergan, a leading branded growth pharma company, I have decided that now is the right time to pursue other career opportunities," said DeFrancesco.
- PR Newswire•5 hours agoAllergan's New Eyepowerment™ Campaign Urges The Up To 33 Million Americans Suffering from Symptoms of Chronic Dry Eye to Take Action
DUBLIN, Feb. 27, 2017 /PRNewswire/ -- "Before we had our voice, we had our eyes," is the powerful opening message from Allergan's new campaign to raise awareness for Chronic Dry Eye. The campaign, titled "Eyepowerment," aims to empower individuals who may be struggling with symptoms of Chronic Dry Eye to talk to their doctor. Research shows emotions are read in one another's eyes, but redness, itching and watering eyes – all common symptoms of Chronic Dry Eye – may unintentionally send the wrong message.
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||243.48 - 245.77|
|52 Week Range||184.50 - 299.11|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.43|
|Dividend & Yield||2.80 (1.14%)|
|1y Target Est||N/A|